Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection.

about

Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation.Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA

P2860

Q52649698-5EE8FA6E-A1AB-4EBF-9270-FCC3DBB62D07 Q57161777-6A823A7A-58C6-4869-9A16-E181EC0FAE5C

P2860

Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection.

Item

http://www.wikidata.org/entity/Q47122200

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Circulating tumor cells as liq ...... fter curative liver resection.

@en

Circulating tumor cells as liq ...... fter curative liver resection.

@nl

type

Item

label

Circulating tumor cells as liq ...... fter curative liver resection.

@en

Circulating tumor cells as liq ...... fter curative liver resection.

@nl

prefLabel

Circulating tumor cells as liq ...... fter curative liver resection.

@en

Circulating tumor cells as liq ...... fter curative liver resection.

@nl

P1476

Circulating tumor cells as liq ...... fter curative liver resection.

@en

P2093

Ansgar W Lohse

http://www.w3.org/2001/XMLSchema#string

Björn Nashan

http://www.w3.org/2001/XMLSchema#string

Florian Ewald

http://www.w3.org/2001/XMLSchema#string

Henning Wege

http://www.w3.org/2001/XMLSchema#string

Johann von Felden

http://www.w3.org/2001/XMLSchema#string

Klaus Pantel

http://www.w3.org/2001/XMLSchema#string

Kornelius Schulze

http://www.w3.org/2001/XMLSchema#string

Sabine Riethdorf

http://www.w3.org/2001/XMLSchema#string

Till Krech

http://www.w3.org/2001/XMLSchema#string

P2860

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Sorafenib in advanced hepatocellular carcinoma

Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Prognosis of hepatocellular carcinoma: the BCLC staging classification

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.

P304

89978-89987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21208

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29163804

http://www.w3.org/2001/XMLSchema#string

P932

5685725

http://www.w3.org/2001/XMLSchema#string

Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection.

about

P2860

P2860

Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932